Corinne Merle

ORCID: 0000-0003-4229-365X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Mosquito-borne diseases and control
  • Malaria Research and Control
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pneumonia and Respiratory Infections
  • Mycobacterium research and diagnosis
  • Diagnosis and treatment of tuberculosis
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Global Maternal and Child Health
  • Respiratory viral infections research
  • Infectious Diseases and Tuberculosis
  • Pharmacovigilance and Adverse Drug Reactions
  • Health Systems, Economic Evaluations, Quality of Life
  • HIV-related health complications and treatments
  • Viral Infections and Vectors
  • Hepatitis C virus research
  • Pharmaceutical studies and practices
  • Inhalation and Respiratory Drug Delivery
  • Sex work and related issues
  • COVID-19 epidemiological studies
  • Immune Cell Function and Interaction
  • HIV, Drug Use, Sexual Risk
  • Influenza Virus Research Studies

World Health Organization
2016-2025

World Health Organization - Pakistan
2024-2025

Special Programme for Research and Training in Tropical Diseases
2015-2024

Cheikh Anta Diop University
2024

Hospital for Tropical Diseases
2021-2024

Progamme National Contre le Tuberculose
2024

London School of Hygiene & Tropical Medicine
2008-2022

Centre Hospitalier Universitaire de Montpellier
2002-2022

Bayero University Kano
2022

Kaduna State University
2022

Shortening the course of treatment for tuberculosis would be a major improvement case management and disease control. This phase 3 trial assessed efficacy safety 4-month gatifloxacin-containing regimen treating rifampin-sensitive pulmonary tuberculosis.We conducted noninferiority, randomized, open-label, controlled involving patients 18 to 65 years age with smear-positive, rifampin-sensitive, newly diagnosed in five sub-Saharan African countries. A standard 6-month that included ethambutol...

10.1056/nejmoa1315817 article EN New England Journal of Medicine 2014-10-22

BackgroundSeasonal malaria chemoprevention (SMC) aims to prevent in children during the high transmission season. The Achieving Catalytic Expansion of SMC Sahel (ACCESS-SMC) project sought remove barriers scale-up seven countries 2015 and 2016. We evaluated project, including coverage, effectiveness intervention, safety, feasibility, drug resistance, cost-effectiveness.MethodsFor this observational study, we collected data on delivery, effectiveness, influence costs impact incidence...

10.1016/s0140-6736(20)32227-3 article EN cc-by-nc-nd The Lancet 2020-12-01

Abstract There is urgent need for new drug regimens that more rapidly cure tuberculosis (TB). Existing TB drugs and vary in treatment-shortening activity, but the molecular basis of these differences unclear, no existing assay directly quantifies ability a or regimen to shorten treatment. Here, we show historically classified as sterilizing non-sterilizing have distinct impacts on fundamental aspect Mycobacterium physiology: ribosomal RNA (rRNA) synthesis. In culture, mice, human studies,...

10.1038/s41467-021-22833-6 article EN cc-by Nature Communications 2021-05-18
Bern-Thomas Nyang’wa Catherine Berry Emil Kazounis Ilaria Motta Nargiza Parpieva and 88 more Zinaida Tigay Ronelle Moodliar Matthew Dodd Varvara Solodovnikova Irina Liverko Shakira Rajaram Mohammed Rassool Timothy D. McHugh Melvin Spigelman David Moore Koert Ritmeijer Philipp du Cros Katherine Fielding Erin Da Costa Nathalie Lachenal Nicola James Animesh A. Sinha Kristen LeBeau Emma Douch Pascal Jolivert Hannah Poulsom Marion Conijn Spencer B. King Hannah Spencer Emma Cunden C Batts Thuy Vuong Sebastian Dietrich Melissa McRae Sidney Wong Eugene Sun Morounfolu Olugbosi Leslie Shanks Michael D. Hughes Payam Nahid Johnstone Kumwenda Todd J. Lorenz S. S. Majumdar C. Robert Horsburgh Eric L. Nuermberger Graeme Meintjes Kathleen D. Eisenach Christian Lienhardt Andrew Nunn Christoph Lange Laura Park Charlotte Gatts Dominic Warren Robert Kleiman George Nyangweso Michael Ochieng Thaddaeus Egondi Kevin Onyango Truphoso Omollo Raymond Omollo Joanna Sturgess Steven Saunders Elizabeth Allen Suzanne Gajewski Valentina Butoescu Jarmila Hanekova Coralie Etter Yerkbulan Kambarov Siza Mphele Victoria Sukhinina Olesya Huzar А. В. Решетников Christine Cilliè Nada Ahmed Robert Hunt Corinne Merle Allanazarova Gulayim M. Mbenga Zlikha Saparbaevna Baltasheva Tleubergen Abdrasuliev Hasmik Margaryan Utemuratova Gozzal Urgenishbaevna Alena Skrahina Natalia Yatskevich Dzmitry Viatushka Tatsiana Apanasevich Aliaksandr Skrahin Lynette Duckworth Cindy Narasimooloo Ndlovu Ellah Lesego Sharon Motlhako Mamomoko Ephenia Mashamaite Evelyn Mojapelo

BackgroundAround 500 000 people worldwide develop rifampicin-resistant tuberculosis each year. The proportion of successful treatment outcomes remains low and new treatments are needed. Following an interim analysis, we report the final safety efficacy TB-PRACTECAL trial, evaluating oral regimens for tuberculosis.MethodsThis open-label, randomised, controlled, multi-arm, multicentre, non-inferiority trial was conducted at seven hospital community sites in Uzbekistan, Belarus, South Africa,...

10.1016/s2213-2600(23)00389-2 article EN cc-by The Lancet Respiratory Medicine 2023-11-16

Abstract Background Only 63% of patients initiating multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment in 2020 were treated successfully. 24-Week all-oral bedaquiline, pretomanid, and linezolid (BPaL)–based regimens have demonstrated higher rates success been recommended by the World Health Organization. Operational research is urgently required to evaluate these non-trial settings. Methods This was a prospective cohort study with microbiologically confirmed...

10.1093/cid/ciaf035 article EN cc-by-nc-nd Clinical Infectious Diseases 2025-01-22

Spinal cord injury (SCI) patients with neurogenic bladder have an increased risk for symptomatic urinary tract infection (UTI). Recurrent UTI requires multiple courses of antibiotic therapy, markedly increasing the incidence multidrug-resistant (MDR) bacteria.During observational prospective study, we determined safety and efficacy a weekly oral cyclic (WOCA) regimen to prevent in SCI adult undergoing clean intermittent catheterization. The WOCA consisted alternate administration once per...

10.1093/jac/dkl010 article EN Journal of Antimicrobial Chemotherapy 2006-02-10

The currently recommended doses of rifampin are believed to be at the lower end dose-response curve. Rifampin induces its own metabolism, although effect dose on extent autoinduction is not known. This study aimed investigate using a semimechanistic pharmacokinetic-enzyme turnover model. Four different structural basic models were explored assess whether scaling methods affected final covariate selection procedure. Covariates selected by linearized approach. model included allometric oral...

10.1128/aac.05792-11 article EN Antimicrobial Agents and Chemotherapy 2012-01-18

10.1016/j.cmi.2016.11.014 article EN publisher-specific-oa Clinical Microbiology and Infection 2016-11-27

BackgroundThe Xpert MTB/RIF (Xpert) assay is used globally to rapidly diagnose tuberculosis and resistance rifampicin. We investigated the frequency predictors of false-positive findings rifampicin with Xpert.MethodsWe did a prospective, observational study individuals who were enrolled in Rwandan nationwide diagnostic cohort (DIAMA trial; NCT03303963). included patients identified have on initial testing. repeat rpoB Sanger deep sequencing alongside phenotypic drug susceptibility testing...

10.1016/s2666-5247(20)30007-0 article EN cc-by-nc-nd The Lancet Microbe 2020-06-01

Abstract Background Globally rifampicin-resistant tuberculosis disease affects around 460,000 people each year. Currently recommended regimens are 9–24 months duration, have poor efficacy and carry significant toxicity. A shorter, less toxic more efficacious regimen would improve outcomes for with tuberculosis. Methods TB-PRACTECAL is an open-label, randomised, controlled, phase II/III non-inferiority trial evaluating the safety of 24-week containing bedaquiline pretomanid to treat Conducted...

10.1186/s13063-022-06331-8 article EN cc-by Trials 2022-06-13

SMC was adopted in Nigeria 2014 and by 2021 being implemented 18 states, over four months between June October 143000 community drug distributors (CDDs) to a target population of 23million children. Further expansion is planned, extending 21 states with or five monthly cycles. In view this massive scale-up, the National Malaria Elimination Programme undertook qualitative research shortly after campaign understand attitudes so that these perspectives inform future planning delivery Nigeria.

10.1186/s12936-023-04547-w article EN cc-by Malaria Journal 2023-04-11

Sources and Assessment of Occupational Stress in the Police: Frédéric Deschamps, et al. Department Health, Faculté de Médecine, Reims, France —The role police Western society is undergoing a transformation that reflects economic social technological changes community assertion individual rights within democracy. The aim this study to evaluate level stress among group French policemen examine association between policing, potential stressors levels. sample drawn from large metropolitan force...

10.1539/joh.45.358 article EN Journal of Occupational Health 2003-11-01

Of three first-line anti-tuberculosis (anti-TB) drugs, isoniazid is most commonly associated with hepatotoxicity. Differences in INH-induced toxicity have been attributed to genetic variability at several loci, NAT2, CYP2E1, GSTM1and GSTT1, that code for drug-metabolizing enzymes. This study evaluated whether the polymorphisms these enzymes were an increased risk of anti-TB drug-induced hepatitis patients and could potentially be used identify liver injury.In a cross-sectional study, 2244...

10.1371/journal.pone.0085905 article EN cc-by PLoS ONE 2014-01-23

Despite marked progress in Senegal, three regions the southeast part continue to have a high burden of malaria, but there been no recent studies assessing prevalence malaria associated with pregnancy. This study aimed determine infection pregnant women attending antenatal clinics Senegal. During transmission season 2019, 11 health care facilities for scheduled visit and those presenting unwell signs were invited participate screening study. A finger prick blood sample was taken diagnosis by...

10.4269/ajtmh.23-0164 article EN cc-by American Journal of Tropical Medicine and Hygiene 2024-01-02

Persistent immune activation in virologically suppressed HIV-1 patients, which may be the consequence of various factors including microbial translocation, is a major cause comorbidities. We have previously shown that different profiles distinguished virological responders. Here, we tested hypothesis particular profile might translocation. To this aim, measured 64 soluble and cell surface markers inflammation CD4+ CD8+ T-cell, B cell, monocyte, NK endothelial 140 adults under efficient...

10.3389/fimmu.2019.02185 article EN cc-by Frontiers in Immunology 2019-09-13
Corinne Merle Ndeye Astou Badiane Cyriaque Affoukou Souliatou Yolande Affo Luc Djogbénou and 89 more Aurore Ogouyemi Hounto Sidzabda Kompaoré Issa Nébié Marcellin Joël Ateba Andreas Ateke Njoh Dominique Bomba Shalom Ndoula Tchokfe Innocent Mbulli Ali Fatou Camara Momar Mbodj Stephen Sosler Josea Rono Lizzie Noonan Muniratu Venu Mohamed Naziru Tanko Thomas Gyan Margaret Gyapong Jose Ernesto Nante Humberto Imbunda Intchala Mohamed Binné Camara Guéladio Cissé Jonas Emile Loua Rose Jalang’o Paul Milligan Susana Scott K. Scott Baker John Sande Brenda Lupafya Mhone Aissata Koné Yacouba Coulibaly Ibrahima Diarra Andre Marie Tchouatieu Miriam Aliaprieto Ibrahim G. Diallo Yahaya Abou Abdoul Nasser Assan Hadiza Jibril Nigeria Nmep N. C. Eze Garba Bello Bakunawa Emmanuel Shekarau Jamilu Nikau Scott Gordon Elizabeth Ann Wilskie John Bawa Ndeye Astou Badiane Katharine Sturm‐Ramirez Jean Pierre Kidwang Doudou Sène Jean Standeur Nabykaly Ka Abdoulaye Mahamat Saleh Issakha Diar A. Addi Branwen J. Hennig Gildas A. Yahouédo Olimatou Kolley Sidat Fofana Mbye Nijetinah Atcha-Oubou Hezouwe Looky Djobo Rokhaya Mbaye Sani Ousmane Jean Louis Ndiaye Amadou Sow Ibrahima Mbaye Fatimata Bintou Sall Ndèye Fatoudiop Léontine Ndogou Bakhoum El Hadji M. B. Diouf L. Y. Almamy Youssouph Khady Ndiaye Belynda Amankwa Les Ong Cecilia Oh Bill Wirngo L.E. Kung Judith Hedje Lydia Tuitai Oniovo Efe-Aluta Mgaywa Gilbert Mjungu Damas Magafu Spes Caritas Ntabangana Mouctar Kande Rafiq Okine Mary J. Hamel Jenny A. Walldorf Eliane Furrer Kristen Kelleher William Lindsey Mayuko Takamiya C. Bergstrom

Abstract A workshop on implementation strategies for the introduction of RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas highly seasonal transmission, was held as a hybrid meeting Dakar, Senegal, and online, 23–25 January 2023. Delegates from Expanded Programmes Immunization (EPI) National Malaria Control (NMCPs) 13 African countries, representatives key stakeholders participated. RTS,S is first to be recommended by World Health Organization (WHO). The recommendation followed...

10.1186/s12936-023-04657-5 article EN cc-by Malaria Journal 2023-08-23

BackgroundProgress in tuberculosis control China has been the slowest western areas, which have highest prevalence. We assessed prevalence of pulmonary Xinjiang province, China, 10 years after introduction a programme based on directly observed treatment, short course.MethodsIn this population-based, cross-sectional survey, we used multistage stratified random cluster sample design to estimate smear-positive and bacteriologically confirmed (either smear positive or culture positive, both)...

10.1016/s2214-109x(16)30074-2 article EN cc-by-nc-nd The Lancet Global Health 2016-06-06
Coming Soon ...